The SR-B1 Receptor as a Potential Target for Treating Glioblastoma

Table 1

Chemical composition of rHDL/EVR nanoparticles.

Component	mg/mL ± SD	Component % of total ± SD
EVR	0.57 ± 0.09	9.3 ± 1.4
Protein	1.23 ± 0.04	20.1 ± 0.7
Phospholipid	3.72 ± 0.19	60.7 ± 3.2
Cholesterol	0.61 ± 0.04	10.0 ± 0.6